This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned, self-certified small disadvantaged biotechnology company located in Malvern, Pennsylvania. The $6,230 firm-fixed-price contract was awarded on March 12, 2010 for the delivery of a KI vector constructed with interleukin-17A (IL-17A)....
<p>The National Heart Lung and Blood Institute (NHLBI) awarded a $611,500.00 firm fixed-price purchase order contract to Vector Biomed Inc. for the production of a lentiviral vector, CX170. This contract, which does not have a set-aside designation, has a completion date of September 2, 2027. The place of performance is in NO POTOMAC, MD 20878, USA.</p>
Vector Biosystems, Inc., doing business as Vector Biolabs, has been awarded a firm fixed-price purchase order valued at three thousand six hundred twenty-five U.S. dollars ($3,625) by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA). The contract term is from November 24, 2017 through November 23, 2018 for Vector Biolabs to provide unspecified products or services to NIAAA in support of its biomedical research programs. Place of performance will be...
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $18,728 firm fixed price purchase order to Vectorbuilder Inc. for the generation of an OCVAR8 stable cell line plasmid synthesis services. This contract does not have a set-aside designation, indicating that Vectorbuilder competed for the award in full and open competition. Vectorbuilder is a specialized biotechnology company that provides molecular...